Skip to content

Privacy Policy

Tirzepatideoral does not collect personal data on this site. Analytics is aggregated and anonymous.

Reviewed by the Tirzepatideoral Research Team · Last updated February 2026

References & Scientific Sources

  1. Frias JP, et al. Tirzepatide vs semaglutide in type 2 diabetes (SURPASS-2). N Engl J Med. 2021.
  2. Rosenstock J, et al. Efficacy and safety of tirzepatide monotherapy (SURPASS-1). Lancet. 2021.
  3. Ludvik B, et al. Tirzepatide versus insulin degludec (SURPASS-3). Lancet. 2021.

Sources are provided for educational reference. This content is informational and not a substitute for professional medical advice.